Ursal, Kent B.

HRN: 22-41-36  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2023
CEFUROXIME 750MG (VIAL)
08/23/2023
08/30/2023
IV
216mg
TID
PCAP-C; AGE W/ Mod. Dehydration
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: